YGYing-Qiang Guo

Ying-Qiang Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ying-Qiang Guo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Ben-Gui Zhang

    Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China

    1 shared publication
  • Ben-Gui Zhang

    Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Jun Shi

    Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China

    1 shared publication
  • Jun Shi

    Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Wen-Jun Ren

    Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China

    1 shared publication
  • Zhi-Xuan Bai

    Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China

    1 shared publication

Latest Publications

  • Open Access

    A modified Cox maze IV procedure: a simpler technique for the surgical treatment of atrial fibrillation

    by Jun Shi, Zhi-Xuan Bai, Ben-Gui Zhang, Wen-Jun Ren, Ying-Qiang Guo

    To determine the effectiveness of a simplified surgical treatment method for atrial fibrillation (AF). Between September 2012 and October 2013, 120 patients (mean age, 52.3 ± 8.8 years) underwent valve surgery and concomitant bipolar radiofrequency ablation for the treatment of AF. Patients were randomized to a Cox maze IV procedure (CMP-IV) group (n = 60) or a modified CMP-IV (MCMP-IV) group (n = 60). Freedom from AF was defined as freedom from any left atrial arrhythmia lasting P < 0.001). The mean follow-up time was 32.4 ± 3.6 months (range, 26–39 months). Freedom from AF tended to be higher, but not significantly so, among the MCMP-IV group than among the CMP-IV group over the entire follow-up period. The MCMP-IV is an effective surgical procedure for the treatment of AF. In certain patients, such as those with anatomic variations of the pulmonary veins, the MCMP-IV is simpler than the CMP-IV. ChiCTR-TRC-12002742.


  • Open Access

    Papillary fibroelastoma of the aortic valve in association with rheumatic heart disease: a case report

    by Jun Shi, Zhi-Xuan Bai, Ben-Gui Zhang, Ying-Qiang Guo

    Papillary fibroelastoma (PFE) is a rare primary cardiac neoplasm that is usually discovered incidentally at autopsy or during cardiac surgery. PFE combined with rheumatic heart disease (RHD) is extremely rare, and only a few cases have been reported. Additionally, the growth rate of the tumor is unknown. Here, we present a very rare case of PFE of the aortic valve combined with RHD, which were identified in a female patient who survived for 5 years without surgical intervention, and who subsequently underwent successful surgical treatment. PFEs may be generally slow-growing tumors, however, the better treatment of choice may be surgery because it produces good curative effects with very low risk of complications, while preventing serious disease consequences.